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I. INTRODUCTION
HIV/AIDS is a global pandemic that currently affects over 150 million people 
around the world (Barnett and Whiteside 9). Over 40 million individuals have the 
disease; until a cure is found, the socio-economic impact of HIV/AIDS will continue to 
escalate (Barnett and Whiteside 364). This is especially true in Sub-Sahara Africa, where 
most of the epidemic is concentrated. South Africa alone represents 13% of the world’s 
total HIV positive population (Avert 1). Aside from the casualties resulting from AIDS-
related deaths, the social impact from AIDS should also be considered. HIV/AIDS is 
labeled as a socio-economic disease, meaning the disease effects the social structures and 
economies of those nations heavily infected. The AIDS problem is compounded in poor 
countries as a lack of infrastructure and funding make the challenge of fighting AIDS 
much more difficult. HIV continues to affect the most socially productive sectors in 
society, those between the ages of 15-50 (Barnett and Whiteside 1).  
Given the latent nature of the disease and the lack of strict reporting regulations in 
Africa, one can conclude that the total reported number of HIV infections is vastly 
underestimated. This in turn suggests that the costs associated with the disease are also 
underestimated. Given the growing global prevalence of HIV/AIDS, an in-depth study of 
the relevant costs associated with the unchecked epidemic can provide useful information 
to policy makers who determine ultimately how much funding should be allocated to 
further study the disease. The relevant costs associated with HIV/AIDS that are currently 
considered, namely health-care expenses and wage losses from leaving the workforce, 
represent only a fraction of actual costs incurred. Measuring the comprehensive costs of 
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HIV/AIDS becomes even more important for third world nations, as the rapid spread of 
HIV/AIDS in these countries will be especially problematic for their less-than-stable 
economies. Therefore, the study that will be the basis for my project will be designed to 
take place in sub-Sahara Africa, with a particular emphasis on the two most heavily 
infected countries: Botswana and South Africa.  
Little is known about the total HIV/AIDS costs incurred by individuals, families 
and society. Documenting these costs is important for several reasons: developing 
feasible disease management strategies, allocating research dollars for biomedical 
research and development, and understanding, in-depth, the cost burden distribution. The 
ultimate goal of the project is to encourage people, communities and governments to 
mobilize in light of these findings.  
 
II. BACKGROUND RESEARCH 
Kennedy Gaichiri, a Wharton Research Scholar alum, conducted research to 
identify the South African province most in need of public health intervention at the 
firm/industry level. His research was used in conjunction with a project Dr. Ian 
MacMillan had undertaken. Professor MacMillan undertook a project to develop a 
workforce health management system that would allow companies to optimally 
determine drug/nutrition regimens for a population of workers in firms located in 
countries with high HIV positive workforces. One specific component of his project 
included the development of a software system that would take limited input data about 
individual workers and infer the most cost effective model for distributing limited 
nutrition and drug supplies to maintain the vitality of infected workers.  
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James Thompson, Director of the Societal Wealth Program at the University of 
Pennsylvania, along with Dr. MacMillan, has done research specifically looking at the 
direct and indirect costs of HIV/AIDS with respect to employees at the firm level. Such 
costs include re-hiring costs, decreased productivity and/or quality of work, and paid sick 
leave.  
 
III. RESEARCH QUESTIONS
First, I focused on exploring different HIV/AIDS social impact studies to assess 
which cost measuring technique is most appropriate. After I found an appropriate study, I 
then proceeded to determine exactly how it was conducted. I looked at logistics, data 
collection, and analysis procedures. Some examples of the logistics I explored include 
costs of the study, sample size and time frame of the study. The need for such research is 
practical because if approved, a research project of this nature will likely cost between 
$1.2-$1.4 million to implement.  
 
IV. FINDINGS
A. FINDING A COMPARABLE STUDY  
The first step in designing the AIDS proposal was to find an appropriate study 
that could be replicated for HIV/AIDS. There have been several AIDS impact studies 
done in the past. A common element among these social impact studies is the use of a 
“macroeconomic” measurement technique. The vast majority of HIV/AIDS related 
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studies previously completed use complex economic equations to assess total costs. For 
example, the One-Sector Neoclassical Growth Model (also known as the human capital 
approach) views GDP as a function of total factor productivity, capital accumulation, the 
growth rate of labor, and labor productivity (Haacker 5). By “tweaking” the parameters 
of the equation, economists at the International Monetary Fund hope to capture the 
economic impact of AIDS as it relates to a shrinking and less productive workforce. The 
Neoclassical Growth Model estimates parameters for  
formulas such as the one above to assess output. Here, Y represents GDP and the right-
hand side variables relate to the labor market.  Using the equation above, the total 
estimated costs of the epidemic in 2000 amounted to 2.3-4% of GDP, with direct costs 
equaling 1.8-3.6% of this estimate (CADRE 13).Though these commercial forecasting 
models may be able to provide a ball-park figure for the social impact of HIV/AIDS, 
there is probably a high degree of uncertainty surrounding the actual estimates. This 
approach is also used by organizations such as the Center for AIDS Development, 
Research, and Education (CADRE) although with slight modifications to the GDP 
equation (CADRE 12). The Dual Economy approach, also used by the International 
Monetary Fund, is similar to the Neoclassical Growth Model with the exception that it 
uses both skilled and unskilled labor as factors of total GDP (Haacker 6). Still, this 
approach also generalizes the effects of the epidemic and is likely to underestimate the 
true costs of the disease. There are inherent difficulties involved in modeling work of this 
nature because several assumptions are necessary. First, labor force mortality estimates 
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are translated into ‘efficiency units’ using average wages as weights, a common 
procedure but one that underestimates the productivity contribution of experienced 
workers in lower skill categories, and the impact of replacing such workers with 
younger employees (CADRE 14). Secondly, although there is an attempt to take account 
of differential cost impacts across sectors of labor losses, it is not clear that this takes 
into consideration the varying skill compositions in different sectors (CADRE 15).  
A third questionable assumption is the fixing of morbidity losses due to the onset 
of full-blown AIDS in HIV+ workers with surprisingly no differentiation on the basis of 
skill class (CADRE 15).  
 A better approach to modeling the social costs of HIV/AIDS is to use a “bottom-
up” approach. By assessing the total costs of HIV/AIDS at a micro-level and aggregating 
the costs, a more realistic assessment can be made when compared to the macro-level 
GDP figures from before. Thus, my goal became to find a social impact study that used 
this “bottom-up” approach that measured the costs of HIV/AIDS at a mirco-level. The 
micro-level, in this case, refers to measuring the costs of HIV/AIDS at the household 
level. In the search for such a study, we came across a comprehensive multiple sclerosis 
study conducted at Duke University in 1994. The study assessed the household costs 
related to multiple sclerosis and aggregated the findings to determine the annual costs. As 
expected, the results were both unrealized and compelling; the US government responded 
to the findings by increasing funding to multiple sclerosis research.  
The 1994 study was modeled after a similar study led by Dr. Robert Inman in 
1976 which also calculated the economic losses resulting from multiple sclerosis.  Given 
the vast similarities between multiple sclerosis and HIV (average age of onset, high cost 
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of treatment, physiological similarities etc.), one can safely use the mechanics of the 
multiple sclerosis study as a basis for a new HIV study. Although there were a  few 
crucial costs that were neglected in the 1976 study but captured in the 1994 study, the 
1976 study included a diary given to each participant and his/her spouse to document 
every cost, emotional reaction etc. to the disease for the given time period. This 
component of the 1976 study was left out of the 1994 study but should be included in the 
HIV/AIDS proposal as the findings in Dr. Inman’s journals shed light upon previously 
unrealized costs.  Thus the 1994 Duke University MS study, with the journal component 
of the 1976 MS study, became the basis for framing the proposal for the HIV/AIDS 
impact study.  
 
B. MULTIPLE SCLEROSIS STUDY  
The next step was to contact the head researchers of the Duke University study. I 
was able to reach Dr. Kathryn Whetten Goldstein, Director of the Health Inequalities 
Program at the Terry Sanford Institute of Public Policy at Duke University. The other two 
researchers, Dr. Frank Sloan and Larry Goldstein, are no longer with Duke University 
and couldn’t be reached. By speaking to Dr. Goldstein I attained valuable insight into the 
construction and logistics of the study that could be cross-applied to HIV/AIDS. The 
following describes the logistics of the MS study:  
 
i. PARTICIPANTS 
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National Multiple Sclerosis Society provided researchers with a sample of their 
members who had MS. The sample had individuals in different stages of the disease. 
Individuals were contacted via mail and were over the age of 25, to include only those 
members who were in the workforce. Comparative data was taken from the 1992 Panel 
Study of Income Dynamics to compare individuals with MS with individuals with 
various characteristics over 25. Mean cost utilization of personal health services in the 
general population was also determined.  
To deal with the over-representation of severely disabled MS patients in the study 
(as they are more likely to participate in such a study) weights were applied to total MS 
costs in the ratio of 0.2 for chronic progressive (severely disabled patients) and 0.8 for all 
other MS patients were used.  
Overall costs attributed to MS were determined as separate estimates by MS 
types: chronic progressive vs. all others.  
 
ii. SOURCES OF ECONOMIC COSTS 
INFORMAL CARE (UNPAID ASSISTANCE)
Unpaid personal assistance to patients of MS and job retraining by persons of the 
general population was determined from data from the 1992 Health and Retirement Study 
and the 1993 Asset and Health Dynamics of the Oldest Old. Regression analyses 
computed based upon per ADL (activities of daily living) cost and applying those 
estimates to the general population.  
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Alternative methods for analyzing informal care were used as well. If an 
individual received both formal and informal care, the hourly wage paid for formal care 
was applied to the informal care. If the respondent received informal but no formal care, 
the mean hourly wage from 1992 Panel Study of Income Dynamics (PSID) was used 
($12.95/hour).   
 
FORMAL CARE (PAID ASSISTANCE)
Formal care expenses were calculated based upon reported hourly payout.  
 
EQUIPMENT/ALTERATIONS (HOME ALTERATIONS SUCH AS RAMPS, LIFTS ETC.) 
These costs include baseline costs for home purchases and/or renovations in 
addition to the following assumptions made in these calculations: useful life of 7 years 
for equipment, 10 years for a vehicle, and 30 years for adaptations to home. Equal 
payments would be made for these alternations over the life of the equipment with a real 
interest rate of 3%.  
 
EARNINGS LOSS (BY MS PATIENT)
Expected earnings of individuals without MS were derived using population-
based predicted labor force participation and wage numbers using the PSID. Individual 
specific earnings losses were estimated by subtracting actual from predicted work hours 
and multiplying by the predicted wage. These calculations were made over the working-
life of the individual and discounted (real discount rate of 3%) back to 1994 to estimate 
the prevent value terms of an MS individual’s earnings losses. Separate estimates were 
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made for eight subgroups by occupation and gender. A weighted mean was then 
calculated using the proportion of each group from the sample size. Past loss (prior to 
1994) and future loss over time was based upon the current value of personal services and 
equipment expenditures and current lost value which came from total loss earnings.  
 
PERSONAL HEALTH CARE (HOSPITAL, PHYSICIAN, PRESCRIPTION DRUGS)
Personal health care costs were estimated as the product of the fraction of 
individuals using a particular service by the mean number of units of the service (i.e. 
hospital days) and by the national mean cost of the unit.  
 
INFLATION  
Costs incurred before 1994 were inflated to 1994 dollars using the CPI.   
 
iii. SOURCES OF COMPENSATION 
INCOME SUBSIDIES  
The subsidies considered include: private disability insurance, unemployment 
compensation, worker’s compensation, benefits, supplemental security income, Social 
Security when < 65, and food stamps.  
Compensation was also computed for other services, equipment and earnings loss. 
For services other than informal care, the survey obtained information on out-of-pocket 
expenditures. The subsidy was computed as the differences between estimated 
expenditures and out-of-pocket expenditures. For equipment, the survey obtained 
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information on both total and out of pocket outlays and the subsidy was calculated as the 
difference. For earnings, direct questions on all sources of family income – including 
private and public income subsidies were asked.  
 
iv. FINDINGS OF MS STUDY   
The combined annual total per capita cost of MS was $34,104. Of this, 19% was 
for informal care and $24,421 was borne by MS individuals/families/friends. MS 
individuals bore 71% of the costs for services and insurance/public subsidies financed the 
remaining 29%. Mean lifetime cost in 1994 dollars was $2.2 million (calculated by 
capital value calculations) and total costs amounted between $6.8 - $11.9 billion. Overall, 
almost a fifth of the total cost was for informal care and only 44% of the combined costs 
were for personal health care services.  
Differences between Dr. Inman’s 1976 MS and the 1994 study include: the 
additional expenses of alternations to home and vehicle, the purchase of special 
equipment, the use of less limited health service estimates, and a direct measure of 
informal care cost rather than measuring earnings losses of a spouse. The 1976 estimate 
for the average lifetime cost of MS was $151,000 (Inman55). 
 
V. ADJUSTING FOR HIV/AIDS
The description above outlined the exact costs considered for multiple sclerosis; 
though MS and HIV are comparable diseases, certain costs are/are not relevant for the 
AIDS impact study. For example, the costs associated with equipment and home 
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alternations are substantial for MS patients in the US but will likely be negligible for 
HIV/AIDS patients in sub-Sahara Africa.  When assessing the social costs of AIDS, we 
will look at direct costs, indirect costs and also consider additional costs for which 
specific measurement techniques are not yet known.  
The direct costs that will be considered include formal care (paid assistance), loss 
of wages (patient), personal health expenses, asset sales and funeral expenses. Formal 
care, wage loss and personal health expenses can be documented and accounted for by 
using the journal technique found in Dr. Inman’s 1976 study and/or the survey technique 
used in the 1994 study. Asset sales and funerals sales can likewise be accounted for by 
documentation according to the journal technique and/or survey and the appropriate 
appraisal of assets. Asset sales and funeral expenses are considered because they are 
specific to the HIV epidemic in sub-Sahara Africa. To pay an AIDS patient’s expensive 
anti-retroviral treatment, doctor’s bills etc., families often have to sell or liquidate assets 
such as livestock, bicycles, radios etc (Barnett and Whiteside 191). These costs are 
substantial considering the average annual income of a family in sub-Sahara Africa is 
approximately $1800 (Wikipedia: South Africa). Though the “sale” of an asset is more a 
transfer of wealth and not necessarily a cost, we choose to acknowledge it as a cost at the 
household level. The ultimate purpose of this study is to recognize the huge financial 
costs of HIV/AIDS at a very micro-level to demonstrate that families cannot afford the 
cost burden of HIV/AIDS. Funeral costs are also necessary to consider because of the 
role of funerals in African culture. For many families, funeral costs can amount to more 
than the entire cost of treatment including medication, doctor’s visits, food etc. (Palitza 
3). According to the Joint Economics, AIDS and Poverty Program at the University of 
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KwaZulu-Natal, the average cost of a traditional funeral ceremony in South Africa is 
around $4,900 (Palitza 3). It is often seen as socially inappropriate to not have an 
elaborate funeral for a loved one and thus a substantial amount of household wealth is 
liquidated to afford such a procession.  
Indirect costs include informal care (spouse’s wage losses), psychological costs, 
and business costs. Psychological costs can be measured by the Multiple Sclerosis 
Quality of Life Inventory Test. The MSQLI test was developed by the National Multiple 
Sclerosis Society and consists of a series of straightforward questions related to quality of 
life, emotional state and mental stability (MSQLI 1).  The questions asked in the survey 
are not unique to multiple sclerosis and therefore, can be easily translated and tailored to 
a South African audience. Business costs stemming from HIV/AIDS include: employee 
productivity losses (as measured by the MSQLI test), on the job accidents (as measured 
by small enterprise surveys), absenteeism (as measured by small enterprise surveys), and 
increased health care costs such as insurance, early retirement withdrawals etc. (as 
measured by small enterprise surveys). Such data is already being collected and analyzed 
by James Thompson. 
Other additional costs that will be given consideration is the overall decline in 
productive human capital and the orphan burden. Though there is no established 
mechanism by which we can measure these additional costs, a buffer should at least be 
included in the final assessment to address these issues. As AIDS continues to take the 
lives of those within the 15-50 age range, more and more children are becoming 
orphaned. As of 2003, approximately 1.1 million AIDS orphans were living in South 
Africa alone (AIDS Foundation 4). These orphans have traditionally been adopted by 
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extended family who are expected to absorb the additional costs of these children 
(Barnett and Whiteside 208). However, as more and more children are orphaned, these 
extended family networks will not be able to afford to take them in. Therefore the 
increased household expenditure due to orphaned children needs to be documented and 
aggregated. The second additional cost to consider is related to future generations of 
uneducated children. Families with HIV positive individuals are increasingly pulling their 
children out of school to help pay for related expenses and take care of family members 
at home (Avert 6). Additionally, teachers are increasingly becoming recognized a fast 
growing “risk group” for HIV/AIDS. Most teachers are women, and women are socially 
and physiologically more susceptible to HIV/AIDS then men (Farmer 24). As of 2004, 
approximately 4,000 teachers died of AIDS in South Africa and 2,300 were infected 
(McElligott 5). The combination of fewer educated children and a shrinking teaching 
workforce will result in a generation of children in sub-Sahara Africa who will not be 
productive workers. In the future, firms cannot reasonably expect to find local human 
capital that can meet the demands of a competitive global market. The future costs 
associated with this decline in productive human capital need to be discounted to today if 
an accurate assessment of the social costs of HIV/AIDS is to be made.  
To offset some of the costs associated with HIV/AIDS, some forms of 
compensation need to be considered. Insurance benefits for skilled labor workers, health 
insurance, death insurance, early retirement benefit withdrawals etc. can be documented 
by either the family or the firm. Government subsidies to anti-retrovirals also need to be 
considered and documented at either the family or government level. Though government 
subsidies aren’t as common in sub-Sahara African, in countries such as Brazil, the 
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government pays for all anti-retroviral treatment at no cost to the patient (Seligman and 
Resende 12).  
The scope of the project also needs to be reconsidered for HIV/AIDS. Though 
patients with MS were randomly selected to participate and both progressive and non-
progressive patients were used, the patient sample for the HIV/AIDS study will be strictly 
non-progressive. That is, a cross-section of patients will be taken who have been 
diagnosed with HIV at t=0; these individuals will continue to be monitored through time 
as the disease progresses from HIV to AIDS.  
Once the structure of the project was determined, the next step was to identify 
how the data is to be collected and analyzed. Dr. Whetten-Goldstein and her team used 
the services of Mathematica Policy Research to construct the surveys that were 
administered and then analyze the data. Mathematica Policy Research has several 
experienced researchers and statisticians who have worked on social impact studies of 
this nature in the past. After speaking with the executive director at Mathematica, we 
were told that they would be willing to construct a survey related to HIV/AIDS for the 
purposes of our research. The AIDS survey would be similar to the MS survey; however, 
recognizing that the surveys would be administered in sub-Sahara Africa, the questions 
would be simple and culturally appropriate. MPR currently employs two South African 
researchers who specialize in regional data collection. For the multiple sclerosis 
questionaire, Mathematica surveyed patients regarding: general household information, 
health assessment, cognition, caregiver information, medical services, household 
production (cooking, cleaning etc.), employment, disability, health insurance and 
housing. The assessment of the HIV/AIDS data would not be done by Mathematica, 
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however, but would instead be handled by University of Pennsylvania faculty. Dr. Robert 
Inman has previously been involved with work of this nature where he analyzed and 
quantified both qualitative and quantitative data. Given that the AIDS impact study will 
most likely include a journal assessment, Dr. Inman’s specialty in extracting quantitative 
data from such sources can be of use.   
Essentially, three different methods of measuring costs can be used. First, 
Mathematica Policy Research will be used to develop a detailed questionnaire/survey to 
measure the comprehensive costs of HIV/AIDS at the household/business level. Second, 
the National Multiple Sclerosis Society Quality of Life Inventory Test can be 
administered, evaluated and quantified to translate the psychological impact of the 
disease to actual business costs. Third and finally, the journals of patients can be assessed 
by faculty such as Dr. Inman to shed light on previously unidentified/unclassified costs.  
 
VI. OTHER CONSIDERATIONS
When speaking to Mathematica Policy Research about the feasibility of the 
proposed project, the scope of the social impact study came into question. Though the 
proposed project was feasible, the director questioned as to whether grant sponsors such 
as the Gates Foundations would fund such a large project given that this initiative was 
new with no previous track-record. To address such a concern, the Mathematica team 
suggested that if finding grant sponsorship was difficult for this reason, two smaller pilot 
projects could be run first. The first pilot project would be to continue Dr. MacMillan’s 
firm-level workforce health management system project. The second pilot project would 
involve studying medium-size enterprises across industries in South Africa, with both 
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skilled and unskilled workers, to determine the costs of HIV/AIDS at the firm level. The 
key idea for the second pilot is to identify which industries are most at risk from the 
pandemic.  
 
VII. CONCLUSIONS
HIV/AIDS is a disease process that has caused innumerable social and economic 
losses in the world and on the African continent in particular. Even with relative global 
awareness of the current pandemic, not enough is being done to rescue affected societies. 
The above analysis confirms that HIV/AIDS presents problems to every level of society. 
Given the huge social and economic costs of HIV/AIDS, treatment, education and 
prevention should become a top priority for those nations most heavily affected. Poverty, 
a lack of solid political infrastructure, and inadequate funding, however, make this 
difficult task much more challenging. What the country’s future will look like will be 
determined, to a large extent, by what policies and initiatives are undertaken today to 
combat HIV/AIDS both by the local government and the international community. To 
increase awareness about the future economic impact of AIDS, a study documenting the 
vastly underestimated costs of the disease is crucial. To document the comprehensive 
costs of the disease is a challenging task that requires a lot of thought and planning before 
execution. The purpose of my research is to lay the foundation upon which a thorough 
research proposal and project can be built to meet this challenge.  
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